Curefirst Pharma Private Limited
About Curefirst Pharma Private Limited
Data last updated:
Curefirst Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 01 February 2024.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U21001PN2024PTC227756.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rahul Arun Kohok and Pritesh Champalal Bhandari.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
Company details
Contact details
Curefirst Pharma Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressFl No 404 Wing – B Rohan Tapovan, Sn – 98 Hn – 2A/1A S.B. Road, Pune, Maharashtra, India – 411016
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Curefirst Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Curefirst Pharma Private Limited, buy the company report.
Board of directors of Curefirst Pharma Private Limited
Curefirst Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Arun Kohok | Director | 01 Feb 2024 | 2 Years 8 Months | Current |
| Pritesh Champalal Bhandari | Director | 01 Feb 2024 | 2 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Curefirst Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curefirst Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Curefirst Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Curefirst Pharma Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Pritesh Champalal Bhandari was appointed as Director on 01 Feb 2024.
Frequently asked questions
Curefirst Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 01 February 2024 (2+ years old) and is registered under CIN U21001PN2024PTC227756.
Curefirst Pharma has 2 current directors:
- Rahul Arun Kohok - Director
- Pritesh Champalal Bhandari - Director
The latest financial statements of Curefirst Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Curefirst Pharma is U21001PN2024PTC227756. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curefirst Pharma was incorporated on 01 February 2024, making it 2+ years old. It is registered with the Registrar of Companies, Pune.
Pritesh Champalal Bhandari was appointed as Director on 01 Feb 2024. Rahul Arun Kohok was appointed as Director on 01 Feb 2024.
The registered office of Curefirst Pharma is at Fl No 404 Wing – B Rohan Tapovan, Sn – 98 Hn – 2A1A S.B. Road, Pune, Maharashtra, India – 411016.
Curefirst Pharma operates in the paper industry, in the paper and paper products segment.
Curefirst Pharma can be reached at its registered office: Fl No 404 Wing – B Rohan Tapovan, Sn – 98 Hn – 2A1A S.B. Road, Pune, Maharashtra, India – 411016.
Curefirst Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.